Publicaciones en colaboración con investigadores/as de Universitat de Barcelona (49)

2023

  1. Telomere Length as a New Risk Marker of Early-Onset Colorectal Cancer

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

2022

  1. Familial component of early-onset colorectal cancer: opportunity for prevention

    The British journal of surgery, Vol. 109, Núm. 12, pp. 1319-1325

2021

  1. Development of a severity of disease score and classification model by machine learning for hospitalized COVID-19 patients

    PLoS ONE, Vol. 16, Núm. 4 April

2020

  1. Oncogenic driver mutations predict outcome in a cohort of head and neck squamous cell carcinoma (HNSCC) patients within a clinical trial

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Genetic susceptibility in head and neck squamous cell carcinoma in a spanish population

    Cancers, Vol. 11, Núm. 4

  2. Working towards a consensus on the oncological approach of breakthrough pain: A Delphi survey of Spanish experts

    Journal of Pain Research, Vol. 12, pp. 2349-2358

2017

  1. Analysis of autophagy gene polymorphisms in Spanish patients with head and neck squamous cell carcinoma

    Scientific Reports, Vol. 7, Núm. 1

  2. Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study

    International Journal of Radiation Oncology Biology Physics, Vol. 97, Núm. 3, pp. 473-480

  3. GEIS-21: A multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: A report from the Spanish sarcoma group (GEIS)

    British Journal of Cancer, Vol. 117, Núm. 6, pp. 767-774

  4. Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: A multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS)

    Annals of Oncology, Vol. 28, Núm. 12, pp. 2994-2999

  5. Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics

    Frontiers in Neuroendocrinology, Vol. 45, pp. 25-34

2016

  1. Consenso español sobre los riesgos y detección de la hiperprolactinemia iatrogénica por antipsicóticos

    Revista de Psiquiatria y Salud Mental

  2. Epidemiological characteristics of a Spanish cohort of patients diagnosed with squamous cell carcinoma of head and neck: distribution of risk factors by tumor location

    Clinical and Translational Oncology, Vol. 18, Núm. 11, pp. 1114-1122

  3. Phase II study of panitumumab and paclitaxel as first-line treatment in recurrent or metastatic head and neck cancer. TTCC-2009-03/VECTITAX study

    Oral Oncology, Vol. 62, pp. 54-59

2014

  1. Cognitive outcome and gamma noise power unrelated to neuregulin 1 and 3 variation in schizophrenia

    Annals of General Psychiatry, Vol. 13, Núm. 1

  2. The role of albuminuria in the follow-up of HIV-infected pediatric patients

    Pediatric nephrology (Berlin, Germany), Vol. 29, Núm. 9, pp. 1561-1566

2011

  1. Impact of CD4 T cell count on the outcome of planned treatment interruptions in early-treated human immunodeficiency virus-infected children

    Pediatric Infectious Disease Journal, Vol. 30, Núm. 5, pp. 435-438

  2. Impact of human immunodeficiency virus coinfection on the progression of mother-to-child transmitted hepatitis C virus infection

    Pediatric Infectious Disease Journal, Vol. 30, Núm. 9, pp. 801-804

2010

  1. Antiretroviral-related hematologic short-term toxicity in healthy infants: Implications of the new neonatal 4-week zidovudine regimen

    Pediatric Infectious Disease Journal, Vol. 29, Núm. 4, pp. 376-379

  2. Herpes zoster in healthy infants and toddlers after perinatal exposure to varicella-zoster virus: A case series and review of the literature

    Pediatric Infectious Disease Journal, Vol. 29, Núm. 6, pp. 574-576